Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), National Institute for Occupational Safety and Health (NIOSH), 72416-72417 [2011-30233]
Download as PDF
<![CDATA[
72416
Federal Register / Vol. 76, No. 226 / Wednesday, November 23, 2011 / Notices
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN—Continued
Number of
respondents
Type of data collection
Total ..........................................................................................................
Total burden
hours
9,050
Average
hourly wage
rate
785
Total cost
burden
na
65,233
* Based upon the mean wages tor clinicians (29–1062 family and general practitioners health services managers (11–9111), National Compensation Survey: Occupational wages in the United States May 2010, U.S. Department of Labor, Bureau of Labor Statistics. https://www.bls.gov/
oes/current/oes_nat.htm.
** Based upon the mean wages for clinicians (29–1062 family and general practitioners), National Compensation Survey: Occupational wages
in the United States May 2010, U.S. Department of Labor, Bureau of Labor Statistics. https://www.bls.gov/oes/current/oes_nat.htm.
Estimated Annual Cost to the
Government
components. The maximum cost to the
Federal Government is estimated to be
$166,417 annually.
Exhibit 3 shows the total and
annualized cost by the major cost
EXHIBIT 3—ESTIMATED TOTAL AND ANNUALIZED COST
Cost component
Total cost
Annualized cost
Project Development ...............................................................................................................................
Data Collection Activities .........................................................................................................................
Data Processing and Analysis .................................................................................................................
Project Management ................................................................................................................................
Overhead .................................................................................................................................................
$110,846
47,563
38,250
73,675
62,500
$55,423
23,781
19,125
36,838
31,250
Total ..................................................................................................................................................
332,834
166,417
sroberts on DSK5SPTVN1PROD with NOTICES
Request for Comments
In accordance with the Paperwork
Reduction Act, comments on AHRQ’s
information collection are requested
with regard to any of the following: (a)
Whether the proposed collection of
information is necessary for the proper
performance of AHRQ healthcare
research and healthcare information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (e) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: November 10, 2011.
Carolyn M. Clancy,
Director.
[FR Doc. 2011–30047 Filed 11–22–11; 8:45 am]
BILLING CODE 4160–90–M
VerDate Mar<15>2010
17:03 Nov 22, 2011
Jkt 226001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Dated: November 15, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–30235 Filed 11–22–11; 8:45 am]
Board of Scientific Counselors, Office
of Infectious Diseases: Notice of
Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Board
of Scientific Counselors, Office of
Infectious Diseases, Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS), has been renewed for a
2-year period through October 31, 2013.
For information, contact Robin
Moseley, M.A.T., Designated Federal
Officer, Board of Scientific Counselors,
Office of Infectious Diseases, CDC, HHS,
1600 Clifton Road, NE., Mailstop D10,
Atlanta, Georgia 30333, telephone (404)
639–4461 or fax (404) 235–3562.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Subcommittee for Dose
Reconstruction Reviews (SDRR),
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9 a.m.–5 p.m., Eastern
Time, December 19, 2011.
Place: Cincinnati Airport Marriott, 2395
Progress Drive, Hebron, Kentucky 41018,
Telephone: (859) 334–4611, Fax: (859) 334–
4619.
Status: Open to the public, but without an
oral public comment period. Written
comments may be submitted. To access by
conference call dial the following
E:\FR\FM\23NON1.SGM
23NON1
sroberts on DSK5SPTVN1PROD with NOTICES
Federal Register / Vol. 76, No. 226 / Wednesday, November 23, 2011 / Notices
information: 1 (866) 659–0537, Participant
Pass Code 9933701.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation Program
Act of 2000 to advise the President on a
variety of policy and technical functions
required to implement and effectively
manage the new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines that have
been promulgated by the Department of
Health and Human Services (HHS) as a final
rule; advice on methods of dose
reconstruction, which have also been
promulgated by HHS as a final rule; advice
on the scientific validity and quality of dose
estimation and reconstruction efforts being
performed for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special Exposure
Cohort.
In December 2000, the President delegated
responsibility for funding, staffing, and
operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC.
NIOSH implements this responsibility for
CDC. The charter was issued on August 3,
2001, renewed at appropriate intervals, and
will expire on August 3, 2013.
Purpose: The Advisory Board is charged
with (a) Providing advice to the Secretary,
HHS, on the development of guidelines
under Executive Order 13179; (b) providing
advice to the Secretary, HHS, on the
scientific validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at any
Department of Energy facility who were
exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and
on whether there is reasonable likelihood
that such radiation doses may have
endangered the health of members of this
class. The Subcommittee for Dose
Reconstruction Reviews was established to
aid the Advisory Board in carrying out its
duty to advise the Secretary, HHS, on dose
reconstruction.
Matters to be Discussed: The agenda for the
Subcommittee meeting includes: discussion
of dose reconstruction cases under review
(sets 7–10); DCAS dose reconstruction
quality management and assurance activities;
and dose reconstruction issues from NIOSH
10-year review.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot attend,
written comments may be submitted. Any
written comments received will be provided
at the meeting and should be submitted to
the contact person below well in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary, NIOSH,
CDC, 1600 Clifton Road, Mailstop E–20,
Atlanta, Georgia 30333, Telephone: (513)
533–6800, Toll Free: 1 (800) CDC–INFO,
Email: ocas@cdc.gov.
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
VerDate Mar<15>2010
17:03 Nov 22, 2011
Jkt 226001
pertaining to announcements of meetings and
other committee management activities, for
both the Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: November 17, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–30233 Filed 11–22–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Health and Nutrition
Examination Survey (NHANES) DNA
Samples
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (DHHS).
AGENCY:
ACTION:
Notice.
The National Health and
Nutrition Examination Survey
(NHANES) will not be receiving DNA
proposals in 2012. NHANES is changing
its plan for making DNA available for
genetic research and its proposal
guidelines. NHANES anticipates that
the DNA Bank will be open for
proposals approximately January 2013.
SUMMARY:
Effective date is date of
publication in the Federal Register.
DATES:
Geraldine McQuillan, PhD,
Division of Health and Nutrition
Examination Surveys, National Center
for Health Statistics, Centers for Disease
Control and Prevention, 3311 Toledo
Road, Room 4204, Hyattsville, MD
20782, Phone: (301) 458–4371, Fax:
(301) 458–4028, E–Mail:
NHANESgenetics@cdc.gov.
ADDRESSES:
Dr.
Geraldine McQuillan, Division of Health
and Nutrition Examination Surveys,
National Center for Health Statistics,
Centers for Disease Control and
Prevention, 3311 Toledo Road, Room
4204, Hyattsville, MD 20782,
Phone: (301) 458–4371,
Fax: (301) 458–4028,
E-Mail: NHANESgenetics@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
Juliana K. Cyril,
Deputy Director, Office of Science Quality,
Office of the Associate Director for Science,
Centers for Disease Control and Prevention.
[FR Doc. 2011–30204 Filed 11–22–11; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
72417
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2011–0011]
Public Health Service Guideline for
Reducing Transmission of Human
Immunodeficiency Virus (HIV),
Hepatitis B Virus (HBV), and Hepatitis
C Virus (HCV) Through Solid Organ
Transplantation
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (DHHS).
ACTION: Extension of the public
comment period.
AGENCY:
On September 21, 2011, the
Centers for Disease Control and
Prevention (CDC), located within the
Department of Health and Human
Services (HHS), published a notice in
the Federal Register requesting public
comment on the draft ‘‘Public Health
Service (PHS) Guideline for Reducing
Transmission of Human
Immunodeficiency Virus (HIV),
Hepatitis B Virus (HBV), and Hepatitis
C Virus (HCV) through Solid Organ
Transplantation’’ (76 FR 58517). Written
and electronic comments were to be
received on or before November 21,
2011. However, HHS/CDC has received
requests for a 30 day extension of the
comment period. In consideration of
those requests, HHS/CDC is extending
the comment period by 30 days to
December 23, 2011.
CDC also published a supporting
document for reference, the Evidence
Report. The Evidence Report includes
primary evidence, studies, and data
tables that were used by the Guideline
authors in developing the
recommendations in the Guideline.
The draft Guideline is for use by organ
procurement organizations (OPOs);
transplant centers, including
physicians, nurses, administrators, and
clinical coordinators; laboratory
personnel responsible for testing and
storing donor and recipient specimens;
and persons responsible for developing,
implementing, and evaluating infection
prevention and control programs for
OPOs and transplant centers. This
Guideline provides evidence-based
recommendations for reducing
unexpected transmission of HIV, HBV
and HCV from deceased and living
organ donors.
DATES: Written comments must be
received on or before December 23,
2011.
ADDRESSES: Written comments may be
submitted electronically or by mail. To
SUMMARY:
E:\FR\FM\23NON1.SGM
23NON1
]]>Agencies
[Federal Register Volume 76, Number 226 (Wednesday, November 23, 2011)]
[Notices]
[Pages 72416-72417]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-30233]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee for Dose Reconstruction Reviews (SDRR), Advisory
Board on Radiation and Worker Health (ABRWH or the Advisory Board),
National Institute for Occupational Safety and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), announces the following meeting for the
aforementioned subcommittee:
Time and Date: 9 a.m.-5 p.m., Eastern Time, December 19, 2011.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron,
Kentucky 41018, Telephone: (859) 334-4611, Fax: (859) 334-4619.
Status: Open to the public, but without an oral public comment
period. Written comments may be submitted. To access by conference
call dial the following
[[Page 72417]]
information: 1 (866) 659-0537, Participant Pass Code 9933701.
Background: The Advisory Board was established under the Energy
Employees Occupational Illness Compensation Program Act of 2000 to
advise the President on a variety of policy and technical functions
required to implement and effectively manage the new compensation
program. Key functions of the Advisory Board include providing
advice on the development of probability of causation guidelines
that have been promulgated by the Department of Health and Human
Services (HHS) as a final rule; advice on methods of dose
reconstruction, which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose
estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes
of workers to the Special Exposure Cohort.
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, and will expire on August 3, 2013.
Purpose: The Advisory Board is charged with (a) Providing advice
to the Secretary, HHS, on the development of guidelines under
Executive Order 13179; (b) providing advice to the Secretary, HHS,
on the scientific validity and quality of dose reconstruction
efforts performed for this program; and (c) upon request by the
Secretary, HHS, advise the Secretary on whether there is a class of
employees at any Department of Energy facility who were exposed to
radiation but for whom it is not feasible to estimate their
radiation dose, and on whether there is reasonable likelihood that
such radiation doses may have endangered the health of members of
this class. The Subcommittee for Dose Reconstruction Reviews was
established to aid the Advisory Board in carrying out its duty to
advise the Secretary, HHS, on dose reconstruction.
Matters to be Discussed: The agenda for the Subcommittee meeting
includes: discussion of dose reconstruction cases under review (sets
7-10); DCAS dose reconstruction quality management and assurance
activities; and dose reconstruction issues from NIOSH 10-year
review.
The agenda is subject to change as priorities dictate.
In the event an individual cannot attend, written comments may
be submitted. Any written comments received will be provided at the
meeting and should be submitted to the contact person below well in
advance of the meeting.
Contact Person for More Information: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta,
Georgia 30333, Telephone: (513) 533-6800, Toll Free: 1 (800) CDC-
INFO, Email: ocas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention,
and the Agency for Toxic Substances and Disease Registry.
Dated: November 17, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-30233 Filed 11-22-11; 8:45 am]
BILLING CODE 4163-18-P
